长读定序市场规模、份额和成长分析：按产品供应、按技术、按工作流程、按应用、按最终用户、按地区 - 2025-2032 年行业预测

2023年，全球长读定序市场规模为5.9581亿美元，从2024年的7.7992亿美元扩大到2032年的67.23亿美元，在预测期内（2025-2032年）预计将以30.9的复合年增长率增长。

基因定序市场受到遗传疾病发生率上升、个人化医疗兴起以及第三代定序等技术进步的推动。 COVID-19 大流行进一步加速了诊断和药物开发中对创新测序方法的需求。单分子即时（SMRT）和奈米孔等长读长定序技术越来越受欢迎，因为它们可以准确分析复杂的基因组区域并检测我收集的传统方法经常遗漏的大规模结构异常。这些优点可以实现更有效的诊断，尤其是遗传性疾病。此外，领先公司增加投资预计将推动市场成长，正如旨在开髮用于药物开发和伴同性诊断的先进基因组技术的合作所反映的那样。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境

长读长定序市场规模：依产品分类

• 市场概况
• 消耗品
• 装置
• 服务

长读长定序市场规模：依技术划分

• 市场概况
• 奈米孔定序
• 单分子即时定序
• 定序长读定序

长读长定序市场规模：依工作流程划分

• 市场概况
• 定序
• 样品製备
• 资料分析

长读长定序市场规模：依应用分类

• 市场概况
• 全基因组序列分析
• 标靶定序
• 总体基因体学
• 表观遗传学
• 全EXOME定序
• 其他用途

长读长定序市场规模：依用途

• 市场概况
• 调查
• 临床

长读长定序市场规模：依最终用户划分

• 市场概况
• 学术研究所
• 医院诊所诊断实验室
• 製药和生物技术公司
• 其他最终用户

长读长定序市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Pacific Biosciences of California, Inc.（PacBio）（United States）
• Oxford Nanopore Technologies plc（United Kingdom）
• Illumina, Inc.（United States）
• BGI Genomics Co., Ltd.（China）
• 10x Genomics, Inc.（United States）
• Agilent Technologies, Inc.（United States）
• Thermo Fisher Scientific Inc.（United States）
• QIAGEN NV（Germany）
• Takara Bio Inc.（Japan）
• Danaher Corporation（United States）
• Novogene Co., Ltd.（China）
• New England Biolabs, Inc.（United States）
• Element Biosciences, Inc.（United States）
• Revvity, Inc.（United States）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（United States）
• PerkinElmer, Inc.（United States）
• Roche Holding AG（Switzerland）
• Merck KGaA（Germany）
• Bio-Techne Corporation（United States）

结论和建议

Global Long Read Sequencing Market size was valued at USD 595.81 million in 2023 and is poised to grow from USD 779.92 million in 2024 to USD 6723.02 million by 2032, growing at a CAGR of 30.9% during the forecast period (2025-2032).

The market for genetic sequencing is being driven by the increasing incidence of genetic disorders, the rise of personalized medicine, and advancements in technologies like third-generation sequencing. The COVID-19 pandemic has further accelerated the demand for innovative sequencing methods in diagnostics and drug development. Long read sequencing techniques, such as Single Molecule Real Time (SMRT) and Nanopore, are gaining traction due to their ability to accurately analyze complex genomic regions and detect large structural abnormalities that traditional methods often miss. These advantages allow for more efficient diagnostics, particularly for genetic disorders. Additionally, increased investments from major companies are expected to propel market growth, as seen in partnerships aimed at developing advanced genomic technologies for drug development and companion diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Long Read Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Long Read Sequencing Market Segmental Analysis

Global Long Read Sequencing Market is segmented by Offerings, Technology, Workflow, Application, Usage, End Users and region. Based on Offerings, the market is segmented into Consumables, Instruments and Services. Based on Technology, the market is segmented into Nanopore sequencing, Single-molecule real-time sequencing and Synthetic long-read sequencing. Based on Workflow, the market is segmented into Sequencing, Sample Preparation and Data analysis. Based on Application, the market is segmented into Whole Genome Sequencing, Targeted Sequencing, Metagenomics, Epigenetics, Whole exome sequencing and Other applications. Based on Usage, the market is segmented into Research and Clinical. Based on End Users, the market is segmented into Academic & Research Institutes, Hospitals, Clinics & Diagnostic Labs, Pharmaceutical & Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Long Read Sequencing Market

The Global Long Read Sequencing market is significantly propelled by the growing adoption of next-generation sequencing (NGS) technologies across diverse research domains such as genomics, transcriptomics, and epigenomics. These advanced sequencing methods enable researchers to obtain deeper insights into critical areas like genome assembly, gene expression, and DNA modification patterns. By enhancing the accuracy and completeness of genomic data, long read sequencing becomes an essential tool in NGS-based studies, further driving its implementation in various scientific investigations. This increasing demand for comprehensive genomic analysis fosters the overall growth of the long read sequencing market on a global scale.

Restraints in the Global Long Read Sequencing Market

The global Long Read Sequencing market faces several restraints, notably the high expenses associated with these advanced technologies. Compared to conventional short read sequencing, long read sequencing incurs greater costs related to equipment, reagents, and data analysis. This financial burden can restrict the implementation of long read sequencing methods, particularly in clinical diagnostics and resource-limited research environments, where budget constraints may hinder the widespread adoption of these innovative yet expensive sequencing options. Consequently, the elevated costs present a significant challenge for the growth and accessibility of long read sequencing in various sectors.

Market Trends of the Global Long Read Sequencing Market

The Global Long Read Sequencing market is witnessing robust growth as healthcare and research institutions increasingly adopt these advanced technologies for their superior ability to deliver comprehensive genomic insights. This shift is primarily fueled by the need for accurate genome assembly, structural variant analysis, and complex transcriptomic studies, which short read sequencing often struggles to address. Moreover, the expanding applications in personalized medicine, oncology, and genetic research are amplifying market demand, while technological advancements and reduced costs further enhance accessibility. As a result, long read sequencing is positioning itself as a pivotal tool in the genomics landscape, shaping the future of precision medicine and genetic research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Long Read Sequencing Market Size by Offerings & CAGR (2025-2032)

• Market Overview
• Consumables
• Instruments
• Services

Global Long Read Sequencing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Nanopore sequencing
• Single-molecule real-time sequencing
• Synthetic long-read sequencing

Global Long Read Sequencing Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sequencing
• Sample Preparation
• Data analysis

Global Long Read Sequencing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Whole Genome Sequencing
• Targeted Sequencing
• Metagenomics
• Epigenetics
• Whole exome sequencing
• Other applications

Global Long Read Sequencing Market Size by Usage & CAGR (2025-2032)

• Market Overview
• Research
• Clinical

Global Long Read Sequencing Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Academic & Research Institutes
• Hospitals, Clinics & Diagnostic Labs
• Pharmaceutical & Biotechnology Companies
• Other End Users

Global Long Read Sequencing Market Size & CAGR (2025-2032)

• North America (Offerings, Technology, Workflow, Application, Usage, End Users)
  • US
  • Canada
• Europe (Offerings, Technology, Workflow, Application, Usage, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offerings, Technology, Workflow, Application, Usage, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offerings, Technology, Workflow, Application, Usage, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offerings, Technology, Workflow, Application, Usage, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pacific Biosciences of California, Inc. (PacBio) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Element Biosciences, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations